Akero
fund manager
sector
Healthcare
geography
North America
Vintages
status
Portfolio
category
#Innovative

Akero

Co-invested company
Akero is a clinical-stage company developing innovative treatments for patients suffering from serious metabolic diseases for which there is no treatment.
Offices of Akero, part of the Private Equity manager's portfolio General Atlantic

Akero key figures

100 M
people with non-alcoholic steatosis worldwide
6%
American population with non-alcoholic steatohepatitis
+ 30
health professionals
2017
year established
*Source: Public data from company websites and social networks. For the most up-to-date information, we invite our investors to consult the reports available in their own space.

About Akero

A metabolic disease is a pathology resulting from the absence or dysfunction of certain enzymes required for reactions within our cells.

Akero focuses in particular on non-alcoholic fatty liver associated with metabolic syndrome (abdominal obesity, high cholesterol, diabetes, hypertension, etc.).

The company uses innovative approaches based in particular on gene therapies. Worldwide, the number of people suffering from non-alcoholic steatohepatitis is estimated at between 100 and 180 million.

In the same sector as Akero

Discover our exclusive services
General Atlantic
Odyssey 2021
Odyssey 2021
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio